Introduction
H um an monocytes belong to the mononuclear phagocytes and play an important role in antigen non-specific and antigen-specific immune responses against bacteria, viruses, parasites and tumour cells. Peripheral blood monocytes originate in the bone marrow from pluripotent stem cells which give rise to committed colony forming unit-granulocyte/macrophage precursors (CFU-GM) that differentiate into promonocytes, monoblasts and monocytes. These monocytes leave the bone marrow and enter the cir culation, where they remain for approximately three days (Johnston, 1988) . Peripheral blood monocytes form a heterogeneous population with regard to cell size, density, morphology, phenotype and function (Figdor et al., 1986) . Subsequently, they enter the tis sues and differentiate into tissue-specific macro phages such as Kiippfer cells, histiocytes, alveolar macrophages, microglial cells and osteoclasts, under the influence of factors produced in the local en vironment.
Monocytes express receptors for IL4 and respond to this Th2 cytokine with dramatic changes in mor phology, phenotype and function. Recently, we described a novel cytokine, interleukin-13, and characterized its biological activities (McKenzie et a l, 1993) . IL13 is a protein consisting of 132 aa and has a M W of s 10 kDa. It turns out that IL13 affects hu man monocytes in a similar way as does IL4 (de Waal Malefyt el al., 1993) , and there is evidence that IL4R and IL13R may share a common component which is involved in signal transduction (Zurawski et a l , 1993) . In this paper, we will review the activities of IL4 toward monocytes and compare them with those of IL13.
Effects of IL4 and IL13 on the differentiation of monocytes
Although the effects of IL4 on haematopoiesis are beyond the scope of this communication, some com ments could be made on the effects of IL4 on the differentiation of myeloid cells. IL4 alone has no growth factor activity, but it significantly enhances the growth of granulocyte progenitors from CD 34+ cells or bone marrow from 5-FU-treated mice when IL3, GM-CSF or G-CSF is present (Rennick et al., 1987; Broxmeyer et al., 1988) . However, IL4 has also been shown to inhibit the growth of macrophage pro genitors in human and mouse bone marrow cultured with M-CSF or GM-CSF and inhibited myelopoiesis in the long-term Dexter type of in vitro cultures (Jansen et al., 1989; Rennick et al., 1992) . This could be explained by the fact that IL4 induces the differen tiation of the progenitors into macrophages which are end stage cells that generally do not proliferate. IFNy has been shown to stimulate CFU-M from CD34+ H LA -D R + bone marrow progenitors when IL3, GM-CSF or G-CSF was present, and to inhibit CFU-G in the presence of G-CSF (Snoeck et al., 1993) . IL4 antagonized this activity of IFNy and reversed both the suppression of CFU-G and the en hancement of CFU-M. Antagonistic activities of IL4 and IFNy are also observed on cytokine production and on expression of Fc^R by mature monocytes (see below). IL4 and IL13 induce dramatic changes in the mor phology of peripheral blood monocytes. Monocytes cultured in the presence of IL4 or IL13 form long cytoplasmic protrusions, have a dendritic appearance and adhere strongly to the substrate. Clumping of cells through homotypic interactions can also be ob-(*) To whom correspondence should be addressed. served (te Velde et a l , 1988; McKenzie et a l , 1993) . IL4 or IL13 downregulates the expression o f CD14 and FcyR and upregulates the expression o f class II M H C antigens on monocytes. Based on their m or phology and phenotype, these cells resemble dendritic cells which also express high levels o f class II M H C antigens but d o n 't express FcyR and C D 14. However, dendritic cells express CD1 antigens which are not induced by IL 4 or IL13 on monocytes and appear to be better antigen-presenting cells (Steinman, 1991) .
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Cytokine production by monocytes is inhibited by IL4 and IL13
H um an monocytes and mouse macrophages produce large amounts of a number of cytokines, in cluding IL10, following activation by LPS (de W aal Malefyt et a i 1991; Fiorentino et a l , 1991) . E n dogenously produced IL10 has autoregulatory effects on the production o f cytokines by monocytes and in hibits the secretion of IL 1, IL 6 , I L 8, T N Fa, GM-CSF, G-CSF and IL10 itself. Neutralization of this endogenously produced IL10 by a specific m A b results in enhanced production o f cytokines by LPSactivated monocytes (de W aal M alefyt et aL , 1991) . Under these conditions, IL 4 and IL13 strongly in hibit the production of ILloc, IL ip , I L 6, I L 8, IL10, TNFoc, GM-CSF, G-CSF and M I P la (te Velde et a l , 1990b; Hart et a l 3 1989; de W a a l M alefyt et a l , 1993; M inty et a l , 1993) . Downregulation o f these cytokines has been shown to occur at the m R N A level. IL4, IL13 and IL10 also inhibit the production of IL12 p35, IL12 p40 and IF N a (de W aal M alefyt et a l , 1993; Doherty et a l., 1993) . In addition, IL 4 has been shown to downregulate the production o f M IP-ip (Ziegler et a l , 1991) and platelet-derived growth factor (PDGF) (S. Breitt, pers. com m .) by monocytes. The inhibitory effect of IL 4 on the production o f IL1 and TN Fa has been demonstrat ed on human peripheral blood monocytes, hum an al veolar macrophages, hum an peritoneal macrophages and murine macrophages (Sone et a l , 1992 ; H art et a l , 1991) . Furthermore, IL4 inhibited cytokine production by monocytes activated by IL1, TNFa or IFNy (Lee et a l , 1990; Vellenga et a l , 1991) . However, IL4 and IL13 do not inhibit the produc tion of all cytokines. Both IL 4 and IL13 enhance the production o f IL1 receptor antagonist by LPSactivated monocytes (Fenton et a l , 1992; O rino et a l, 1992; W ong et a l , 1993; de W aal Malefyt, 1993) . Taken together, these data indicate that IL 4 has an tiinflam m atory activities through the inhibition of proinflammatory cytokine production and enhance ment o f IL lr a production, a cytokine which itself possesses antiinflam m atory activities.
IL4 and IL13 modulate expression of Fc receptors
The expression o f Fc receptors by monocytes is strongly influenced by cytokines. IL 4 and I L 13 in duce the expression o f the low affinity Fc receptor for IgE (FceRII, CD23) on the cell surface and IL4 has been shown to induce the release o f soluble CD23 (te Velde et a l , 1990c; Vercelli et a l , 1988; McKen zie et a l , 1993) . This enhanced expression of CD23 may be im portant in allergy, since atopic patients have enhanced Fc&R-mediated cytotoxic activity (Melewiicz et a l , 1981) . M ultiple cytokines are in volved in regulation o f FcyR expression, IFNy and IL10 enhance the expression of FcyRI (CD64), whereas TGFp upregulates the expression of FcyRI (CD16) (te Velde et a l , 1990a Velde et a l , , 1992 W ong et a l , 1991) . IL 4 and IL 13 downregulate the constitutive expression o f all three F c y R : CD64, CD32 and CD 16 (de W aal Malefyt et a l , 1993). A d ditio n o f combi nations of these cytokines showed that IL10 could prevent the IL4~ or IL13-induced downregulation of CD16, CD32 and CD64, whereas IF N y could par tially rescue the IL4-or IL13-induced downregula tion o f CD 64, but not that o f CD32 and C D 16 (de W aal Malefyt et a l , 1993). In addition, IL4 inhibit ed the TGF(3-induced expression of C D 16 (W ong et a l , 1991). FcyRI expression has been correlated with A D C C activity o f monocytes (Tripathi et a l , 1991) . The spontaneous A D C C activity o f monocytes is en hanced by IFN y or IL10 and inhibited by IL4 or IL13 (te Velde et a l , 1990a; te Velde et a l , 1992) . However, IL 4 and IL13 strongly inhibited the IFNy or IL10~induced A D C C activity despite the fact that CD64 expression was not downregulated, indicating that besides CD64 expression, other mechanisms must play a role in the IL4-and IL1.3-induced inhi bition of monocyte cytotoxicity (de W aal Malefyt et a l , 1993) .
IL4 inhibits production of NO and killing of intracellular parasites
Monocytes and macrophages are hosts for a num ber of intracellular parasites, including schistosoma, toxoplasma and leishmania species. Activation of macrophages by IFN y leads to killing o f these in tracellular parasites via production of toxic nitrogen oxide metabolites (James et a l , 1989) . IL4 is able to inhibit the killing o f these intracellular parasites by blocking N O production. IL10 and TGF(3 share this activity with IL4 and combinations o f these factors are synergistic (O sw ald et a l , 1992a) . The ILlO-induced inhibition o f N O production and para site killing is mediated through the downregulation of TNFa production by the monocyte, which acts as a cofactor for the IFNy-induced macrophage activa tion (Oswald et a l , 1992b) . A dditional mechanisms seem to play a role in the IL4-mediated suppression of NO production and parasite killing. However, IL 4 and IL10 inhibit not only intracellular parasites by this mechanism, but also other organisms, like Can dida albicans and Salm onella typhim urium (Cenci et a i , 1993 ; al-Ramadi et a i , 1992) . IL13 and IL4 also inhibited the production of NO by macrophages established from bone marrow by cultures with GM-CSF but not from macrophages grown in M-CSF (Doherty et a l., 1993) . This corresponded to an enhanced survival o f Leishm ania m ajor in the IL13-or IL4-treated GM-CSF cultured macrophages, but not in the IL13 or IL4-treated M-CSF cultured macrophages. IL4 has also been shown to inhibit the IFNy-induced production of reactive oxygen radicals ( 0 ' , H 20 2) (Abramson et a l s 1990; Bhaskaran et a i , 1992) . These mechanisms, together with the in hibited production o f TNFa, IL1 and IL 6, may also explain the IL4-mediated inhibition of IFNyactivated monocytes to kill tumour cells (te Velde et al., 1988) .
Concluding remarks
IL4 and IL13 have dramatic effects on monocyte m orphology, phenotype and function. Both cytokines change the morphology of monocytes, in hibit production o f pro-inflammatory cytokines, in hibit the expression of FcyR and inhibit the production of NO and 0~ which diminishes killing of intra-and extracellular pathogens (de Waal Malefyt et a l., 1993; Doherty et a l , 1993) . In addi tion, IL4 and IL13 inhibit the expression of CD 14, the receptor for the L P S /L P S binding protein com plex and of CD13 (aminopeptidase N), a cell surface marker with enzymatic activity (Van Hal et aL} 1992) . However, IL4 and IL13 also have stimulatory activi ties toward monocytes. IL4 and IL13 enhance class II M H C expression on monocytes, which may be related to an enhanced capacity to present antigen. This has been demonstrated for protein antigens in the mouse and alloresponses in humans (te Velde et a l., 1988; Zlotnik et a l , 1987) . In addition, IL4 and IL13 induce expression of CD23 and enhance the ex pression o f C D llb , C D llc , CD18, CD29 and CD49e (FNR) (de W aal Malefyt et al., 1993) . These (31 and P2 integrins play an important role in cell-cell inter actions and interactions with the extracellular matrix (Hogg, 1989) . The enhanced expression of these an tigens may play a role in the IL4-and IL13-induced changes in adhesion and morphology. Finally, IL4 has been shown to activate 15-lipoxygenase, an en zyme involved in the oxidation of low density lipoprotein (LDL) to its atherogenic form in mono cytes (Conrad et a l , 1992) . This activation could be inhibited by IFNy. Therefore, IL4 could play a role in the pathogenesis of atherosclerosis and the forma tion of foam cells.
IL13 shares many of the known activities of IL4 on monocytes (de Waal Malefyt et a l, 1993 ; Doherty et a l , 1993) . Both cytokines inhibited monocyte func tions which are related to cellular (Thl) immune responses. In addition, it has been shown that IL13, like IL4, induced human B-cell proliferation, B-cell differentiation and IgG4 and IgE production (Punnonen et a l , 1993) . IL13, like IL4, also induced the transcription of the germline t locus and acts as a switch factor (Cocks et a l , 1993) . These results may partially be explained by the finding that IL 4R and IL13R share a common subunit which is involved in signal transduction . IL4 and IL13 are predominantly products of Th2 cells, although human Thl cells are able to produce IL13 (de Waal Malefyt and H. Yssel, in prep.) . IL13 production is more abundantly and longer produced by T-cell clones than IL4. However, in contrast to IL4, IL13 is not active as T-cell growth factor (de Waal Malefyt and H. Yssel, in prep.) . These data in dicate that IL4 and IL 13 may have similar and unique roles in regulation of immune responses despite the fact that both IL4 and IL13 have similar effects on monocyte physiology and function. D N A X is supported by the Sobering Plough Corporation.
